BACKGROUND: It is unclear if mild or moderate mitral valve regurgitation (MR) should be repaired at the time of coronary artery bypass grafting (CABG). We sought to determine the long-term effect of uncorrected MR, measured by intraoperative transesophageal echocardiography (TEE), in CABG patients. METHODS AND RESULTS: Between May 1999 and September 2003, data were gathered for 3264 consecutive patients who underwent isolated CABG and had MR graded by intraoperative TEE. MR was graded on the following 5 levels: none, trace, mild, moderate, and severe. Patients who had severe MR or who underwent mitral valve surgery were eliminated from the analysis. The remaining patients were combined into the following 3 groups: none or trace, mild, and moderate MR. Preoperative and follow-up data were 99% complete. The median length of follow-up was 3.0 years. Multivariable analysis controlling for important preoperative risk factors was performed to determine predictors of death and death/hospitalization for heart failure. Increasing MR was a risk factor for death [hazard ratio (HR), 1.44; P<0.001] and death/heart failure hospitalization (HR, 1.34; P<0.01). When patients with moderate MR were eliminated from the analysis, mild MR was a risk factor for death (HR, 1.34; P=0.011) and death/hospitalization for heart failure (HR, 1.34; P<0.001). CONCLUSIONS: Even mild MR, identified by intraoperative TEE, predicts worse outcomes after CABG. Revascularization alone did not eliminate the negative long-term effects of mild MR. CABG patients with uncorrected mild or moderate MR are at increased risk for death and heart-failure hospitalization; consideration for surgical repair or more aggressive medical management and follow-up is warranted.
BACKGROUND: It is unclear if mild or moderate mitral valve regurgitation (MR) should be repaired at the time of coronary artery bypass grafting (CABG). We sought to determine the long-term effect of uncorrected MR, measured by intraoperative transesophageal echocardiography (TEE), in CABG patients. METHODS AND RESULTS: Between May 1999 and September 2003, data were gathered for 3264 consecutive patients who underwent isolated CABG and had MR graded by intraoperative TEE. MR was graded on the following 5 levels: none, trace, mild, moderate, and severe. Patients who had severe MR or who underwent mitral valve surgery were eliminated from the analysis. The remaining patients were combined into the following 3 groups: none or trace, mild, and moderate MR. Preoperative and follow-up data were 99% complete. The median length of follow-up was 3.0 years. Multivariable analysis controlling for important preoperative risk factors was performed to determine predictors of death and death/hospitalization for heart failure. Increasing MR was a risk factor for death [hazard ratio (HR), 1.44; P<0.001] and death/heart failure hospitalization (HR, 1.34; P<0.01). When patients with moderate MR were eliminated from the analysis, mild MR was a risk factor for death (HR, 1.34; P=0.011) and death/hospitalization for heart failure (HR, 1.34; P<0.001). CONCLUSIONS: Even mild MR, identified by intraoperative TEE, predicts worse outcomes after CABG. Revascularization alone did not eliminate the negative long-term effects of mild MR. CABG patients with uncorrected mild or moderate MR are at increased risk for death and heart-failure hospitalization; consideration for surgical repair or more aggressive medical management and follow-up is warranted.
Authors: Hector I Michelena; Martin D Abel; Rakesh M Suri; William K Freeman; Roger L Click; Thoralf M Sundt; Hartzell V Schaff; Maurice Enriquez-Sarano Journal: Mayo Clin Proc Date: 2010-07 Impact factor: 7.616
Authors: Parag Goyal; Jiwon Kim; Attila Feher; Claudia L Ma; Sergey Gurevich; David R Veal; Massimiliano Szulc; Franklin J Wong; Mark B Ratcliffe; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft Journal: Coron Artery Dis Date: 2015-12 Impact factor: 1.439
Authors: Ethan Kung; James C Perry; Christopher Davis; Francesco Migliavacca; Giancarlo Pennati; Alessandro Giardini; Tain-Yen Hsia; Alison Marsden Journal: Ann Biomed Eng Date: 2014-09-27 Impact factor: 3.934
Authors: Peter K Smith; John D Puskas; Deborah D Ascheim; Pierre Voisine; Annetine C Gelijns; Alan J Moskowitz; Judy W Hung; Michael K Parides; Gorav Ailawadi; Louis P Perrault; Michael A Acker; Michael Argenziano; Vinod Thourani; James S Gammie; Marissa A Miller; Pierre Pagé; Jessica R Overbey; Emilia Bagiella; François Dagenais; Eugene H Blackstone; Irving L Kron; Daniel J Goldstein; Eric A Rose; Ellen G Moquete; Neal Jeffries; Timothy J Gardner; Patrick T O'Gara; John H Alexander; Robert E Michler Journal: N Engl J Med Date: 2014-11-18 Impact factor: 91.245
Authors: Romain Capoulade; Xin Zeng; Jessica R Overbey; Gorav Ailawadi; John H Alexander; Deborah Ascheim; Michael Bowdish; Annetine C Gelijns; Paul Grayburn; Irving L Kron; Robert A Levine; Michael J Mack; Serguei Melnitchouk; Robert E Michler; John C Mullen; Patrick O'Gara; Michael K Parides; Peter Smith; Pierre Voisine; Judy Hung Journal: Circulation Date: 2016-10-25 Impact factor: 29.690
Authors: Joe Luis Pantoja; Liang Ge; Zhihong Zhang; William G Morrel; Julius M Guccione; Eugene A Grossi; Mark B Ratcliffe Journal: Ann Thorac Surg Date: 2014-08-15 Impact factor: 4.330
Authors: Anthony W Castleberry; Judson B Williams; Mani A Daneshmand; Emily Honeycutt; Linda K Shaw; Zainab Samad; Renato D Lopes; John H Alexander; Joseph P Mathew; Eric J Velazquez; Carmelo A Milano; Peter K Smith Journal: Circulation Date: 2014-04-17 Impact factor: 29.690
Authors: Brian C Gulack; Brian R Englum; Anthony W Castleberry; Mani A Daneshmand; Peter K Smith; Louis P Perrault Journal: Ann Cardiothorac Surg Date: 2015-05